Guy Debrock

412 total citations
16 papers, 305 citations indexed

About

Guy Debrock is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Guy Debrock has authored 16 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Guy Debrock's work include Breast Cancer Treatment Studies (6 papers), Frailty in Older Adults (4 papers) and Cancer Treatment and Pharmacology (4 papers). Guy Debrock is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Frailty in Older Adults (4 papers) and Cancer Treatment and Pharmacology (4 papers). Guy Debrock collaborates with scholars based in Belgium, Germany and Switzerland. Guy Debrock's co-authors include Maria Dêbiec‐Rychter, A. Van Oosterom, Raymond Oyen, Raf Sciot, Hans Wildiers, Patrick Neven, Ann Smeets, Willy Peetermans, A. Mewis and Jan Verhaegen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Guy Debrock

16 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guy Debrock Belgium	7	117	103	100	60	48	16	305
Katjana Schwab Germany	12	142 1.2×	74 0.7×	22 0.2×	53 0.9×	32 0.7×	23	285
Antonino Carmelo Tralongo Italy	6	122 1.0×	67 0.7×	46 0.5×	56 0.9×	11 0.2×	19	245
Christopher A. Fausel United States	9	82 0.7×	58 0.6×	16 0.2×	15 0.3×	25 0.5×	23	350
Tianrui Kuang China	10	194 1.7×	107 1.0×	46 0.5×	68 1.1×	70 1.5×	28	360
Chia‐Lin Chou Taiwan	11	117 1.0×	104 1.0×	47 0.5×	65 1.1×	19 0.4×	39	311
Yongyong Ma China	12	136 1.2×	84 0.8×	33 0.3×	27 0.5×	40 0.8×	33	316
Levin Thomas India	10	101 0.9×	153 1.5×	112 1.1×	55 0.9×	29 0.6×	30	364
Vito Michele Garrisi Italy	11	79 0.7×	95 0.9×	57 0.6×	25 0.4×	20 0.4×	16	257
Janine Ziemons Netherlands	9	145 1.2×	249 2.4×	28 0.3×	52 0.9×	30 0.6×	13	465

Countries citing papers authored by Guy Debrock

Since Specialization

Citations

This map shows the geographic impact of Guy Debrock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Debrock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Debrock more than expected).

Fields of papers citing papers by Guy Debrock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Debrock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Debrock. The network helps show where Guy Debrock may publish in the future.

Co-authorship network of co-authors of Guy Debrock

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Debrock. A scholar is included among the top collaborators of Guy Debrock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Debrock. Guy Debrock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wu, Qi, Barbara Brouwers, Bruna Dalmasso, et al.. (2022). Dynamic alterations of immunosenescence-related genes in older women with breast cancer receiving chemotherapy: A prospective study. Translational Oncology. 25. 101527–101527. 5 indexed citations

Quinten, Chantal, Cindy Kenis, Marije E. Hamaker, et al.. (2020). The added value of geriatric assessment in evaluating a patient's Health‐Related Quality‐of‐Life: A study in ≥70‐year‐old early‐stage invasive breast cancer patients. European Journal of Cancer Care. 29(5). e13278–e13278. 6 indexed citations

Quinten, Chantal, Cindy Kenis, Marije E. Hamaker, et al.. (2017). The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥ 70 with early stage invasive breast cancer. Journal of Geriatric Oncology. 9(2). 152–162. 15 indexed citations

Jonge, Evert de, et al.. (2017). Axillary lymph node dissection on the run?. PubMed. 9(1). 45–49. 4 indexed citations

Debrock, Guy, et al.. (2017). The importance of recognizing paraneoplastic symptoms: a case report of Neuroendocrine Small Cell Carcinoma of the Endometrium presenting as Paraneoplastic Cushing's Syndrome.. PubMed. 9(2). 121–126. 2 indexed citations

Brouwers, Barbara, Sigrid Hatse, Lissandra Dal Lago, et al.. (2016). The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters. Oncotarget. 7(21). 29977–29988. 43 indexed citations

Putte, Gregg Van de, et al.. (2015). Outcome of Epithelial Ovarian Cancer. International Journal of Gynecological Cancer. 25(6). 993–999. 2 indexed citations

Brouwers, Barbara, Sigrid Hatse, Lissandra Dal Lago, et al.. (2015). Abstract P4-09-01: Impact of adjuvant chemotherapy on clinical and biological ageing in older breast cancer patients. Cancer Research. 75(9_Supplement). P4–9. 1 indexed citations

Wildiers, Hans, Patrick Neven, Marie‐Rose Christiaens, et al.. (2010). Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancer. Annals of Oncology. 22(3). 588–594. 22 indexed citations

10.

Wildiers, Hans, Patrick Neven, Frédéric Amant, et al.. (2009). Multicenter phase II study of neoadjuvant capecitabine (X), docetaxel (T) ± trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC): final analysis.. Cancer Research. 69(2_Supplement). 5115–5115. 3 indexed citations

11.

Lybaert, Willem, Hans Wildiers, Patrick Neven, et al.. (2007). Docetaxel (T) + capecitabine (X) with or without trastuzumab (H) neoadjuvant therapy for locally advanced breast cancer (BC): Phase II study. Journal of Clinical Oncology. 25(18_suppl). 11042–11042. 3 indexed citations

12.

Lybaert, Willem, Hans Wildiers, Patrick Neven, et al.. (2006). Multicenter phase II study of neoadjuvant capecitabine (X), docetaxel (T) +/- trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC): Preliminary safety and efficacy data. Breast Cancer Research and Treatment. 100. 9 indexed citations

13.

Boudewijns, Michaël, Koen Magerman, Jan Verhaegen, et al.. (2003). Rothia dentocariosa, endocarditis and mycotic aneurysms: case report and review of the literature. Clinical Microbiology and Infection. 9(3). 222–229. 53 indexed citations

14.

Debrock, Guy, et al.. (2003). A phase II trial with rosiglitazone in liposarcoma patients. British Journal of Cancer. 89(8). 1409–1412. 131 indexed citations

15.

Debrock, Guy. (1998). El ingenioso enigma de la abducción. 12(1). 21–40. 5 indexed citations

16.

Debrock, Guy. (1970). La información y el estatuto metafísico de los signos. Communication & Society. 4(1-2). 53–64. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact